Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-01-13
1999-12-14
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 11, 530311, 530317, A61K 3831, A61K 3812, C07K 700
Patent
active
060018011
ABSTRACT:
A cyclic peptide analog of somatostatin wherein a disulfide bond links the N-terminus residue and the C-terminus residue.
REFERENCES:
patent: 4133782 (1979-01-01), Vale, Jr. et al.
patent: 4211693 (1980-07-01), Rivier et al.
patent: 4428942 (1984-01-01), Rivier et al.
patent: 4798821 (1989-01-01), Hartmann
patent: 4853371 (1989-08-01), Coy et al.
patent: 5358934 (1994-10-01), Borovsky et al.
patent: 5506339 (1996-04-01), Coy et al.
patent: 5708135 (1998-01-01), Coy et al.
Fisher et al., "Somatostatin Analog: Plasma Catecholamine Suppression Mediated by the Central Nervous System" Endocrinology 107:714-718, 1980.
Vale et al., "Biologic and Immunologic Activities and Applications of Somatostatin Analogs", Metabolism 27, No. 9, Suppl. 1, pp. 1391-1401, 1978.
Veber et al., "Highly Active Cyclic and Bicyclic Somatostatin Analogues of Reduced Ring Size", Reprint from Nature 280:512-514, 1979.
Coy David H.
Taylor John E.
Biomeasure Inc.
Conway John D.
Tsang Cecilia J.
Tulane Univ. Medical Ctr.
LandOfFree
Cyclic peptide analogs of somatostatin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic peptide analogs of somatostatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic peptide analogs of somatostatin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863411